Acorda Therapeutics Inc
NASDAQ:ACOR 1:27:21 PM EDT
Search For a Symbol
Acorda Therapeutics Inc Stock, NASDAQ:ACOR
2 Blue Hill Plaza, 3rd floor, New York, New York 10965
Number of Employees: 122
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.